Published in Monogr Allergy on January 01, 1989
Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res Ther (2009) 0.93
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 6.71
Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest (1991) 2.97
Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods (1988) 2.84
IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A (1987) 2.37
Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine (1993) 2.37
Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest (1997) 1.98
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.95
A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods (1988) 1.91
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest (1986) 1.70
Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun (1998) 1.67
Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci U S A (1994) 1.66
Induction of compartmentalized B-cell responses in human tonsils. Infect Immun (1995) 1.54
Mucosal immunity: implications for vaccine development. Immunobiology (1992) 1.45
A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci U S A (1997) 1.40
Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am J Trop Med Hyg (1994) 1.40
Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci U S A (1996) 1.38
Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect Immun (1992) 1.33
The detection and specificity of class specific antibodies to whole bacterial cells using a solid phase radioimmunoassay. Clin Exp Immunol (1983) 1.31
Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol (1990) 1.26
Serum levels of immunoglobulin and complement in giant-cell arteritis. JAMA (1976) 1.24
Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol (2010) 1.23
Campylobacter jejuni/coli and enterotoxigenic Escherichia coli (ETEC) in faeces from children and adults in Tanzania. Scand J Infect Dis (1995) 1.23
Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J Immunol Methods (1984) 1.21
Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study. Clin Exp Immunol (1984) 1.19
Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol (1983) 1.18
Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology (1989) 1.15
Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int Arch Allergy Appl Immunol (1986) 1.13
Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man. Clin Exp Immunol (1985) 1.12
On the prevalence, diagnosis and management of lithium-induced hypothyroidism in psychiatric patients. Br J Psychiatry (1977) 1.12
Therapeutic hepatic artery ligation in patients with secondary liver tumors. Rev Surg (1966) 1.10
Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect Immun (1998) 1.10
A simple spot technique for thin layer immunoassays (TIA) on plastic surfaces. J Immunol Methods (1977) 1.09
Adult coeliac patients do tolerate large amounts of oats. Eur J Clin Nutr (2003) 1.08
Comparative testing of precipitation methods for quantitation of C-reactive protein in blood serum. Acta Pathol Microbiol Scand (1968) 1.07
Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol (1983) 1.07
Evaluation of hepatic dearterialization in primary and secondary cancer of the liver. Am J Surg (1972) 1.07
Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur J Immunol (1995) 1.07
Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans. Infect Immun (2001) 1.04
IgA deficiency during D-penicillamine treatment. Br Med J (1977) 1.04
A comparative study on specific antibodies and circulating antigen (CAA) in serum and parasitological findings for diagnosis of schistosomiasis mansoni in an endemic area in Tanzania. Acta Trop (1996) 1.03
High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors. Clin Exp Immunol (1993) 1.03
Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice. Clin Exp Immunol (1986) 1.02
Amplified ELISPOT assay for the detection of HIV-specific antibody-secreting cells in subhuman primates. J Immunol Methods (1992) 1.01
Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect Immun (1994) 1.01
Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1994) 1.00
Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells. Diabetes (1999) 1.00
ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection. AIDS Res Hum Retroviruses (1989) 0.99
Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. J Immunol (1999) 0.98
Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi. Microb Pathog (1995) 0.98
Spontaneous thyroiditis in the obese strain of chickens. VI. Thyroxine-binding antibodies. J Immunol (1971) 0.98
Detection and specificity of antibodies secreted by spleen cells in mice immunized with Streptococcus mutans. Infect Immun (1986) 0.97
Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology (1989) 0.97
Successful treatment of autoimmunity in MRL/1 mice with LS-2616, a new immunomodulator. Arthritis Rheum (1986) 0.97
Vascularisation of liver tumours and the effect of hepatic artery ligature. Bibl Anat (1967) 0.96
Serum enzyme changes after hepatic dearterialization in man. Ann Surg (1968) 0.95
False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents. J Immunol Methods (1983) 0.95
Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine. Arthritis Rheum (1999) 0.95
Effect of hepatic artery ligation on induced primary liver carcinoma in rats. Preliminary report. Acta Pathol Microbiol Scand (1967) 0.94
Thin-layer immunoassay for determination of antibodies to herpes simplex virus. J Clin Microbiol (1979) 0.94
Human complement activation by lipopolysaccharides from bacteroides oralis, fusobacterium nucleatum, and veillonella parvula. Infect Immun (1979) 0.93
Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Scand J Immunol (2006) 0.92
Visceral leishmaniasis in Somalia: prevalence of leishmanin-positive and seropositive inhabitants in an endemic area. Trans R Soc Trop Med Hyg (1995) 0.92
Evaluation of spontaneous autoimmune thyroiditis in chickens of the obese strain (OS) by defined immunofluorescence. Ann N Y Acad Sci (1971) 0.92
Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol (1999) 0.92
Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination. Clin Exp Immunol (1994) 0.92
Induction and molecular properties of secretory and serum IgA antibodies specific for environmental antigens. Ann Allergy (1987) 0.91
An immunoenzyme procedure for enumerating fibronectin-secreting cells. J Immunoassay (1984) 0.91
Immunological changes in patients with previous malignant essential hypertension. Lancet (1981) 0.91
Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies. Clin Immunol Immunopathol (1987) 0.90
Demonstration of Rh antigens in a 38-day-old fetus. Am J Obstet Gynecol (1967) 0.90
Production of antibodies to gliadin in intestinal mucosa of patients with coeliac disease: a study at the single cell level. Gut (1989) 0.90
Incidence and prevalence of dermatitis herpetiformis in western Sweden. Acta Derm Venereol (1984) 0.90
A second variant of properdin deficiency: the detection of properdin at low concentrations in affected males. Complement (1988) 0.90
C-reactive protein in serum from infants as determined with immunodiffusion techniques. II. Infants with various infections. Acta Paediatr Scand (1970) 0.89
Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease. Agents Actions (1990) 0.89
Combined immunomagnetic cell sorting and ELISPOT assay for the phenotypic characterization of specific antibody-forming cells. J Immunol Methods (1997) 0.89
Plasma protein accumulation in injured endothelial cells. Immunofluorescent localization of IgG and fibrinogen in the rabbit aortic endothelium. Exp Mol Pathol (1979) 0.89
Natural antibodies in man to Streptococcus mutans: specificity and quantification. Immunology (1984) 0.89
Anatomic segmentation of the intestinal immune response in nonhuman primates: differential distribution of B cells after oral and rectal immunizations to sites defined by their source of vascularization. Infect Immun (1999) 0.89
Lack of interferon-gamma receptor does not influence the outcome of infection in murine schistosomiasis mansoni. Scand J Immunol (1996) 0.89
Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. Clin Exp Allergy (2000) 0.88
Serum gliadin antibodies for detection and control of childhood coeliac disease. Acta Paediatr Scand (1984) 0.88
Normal human sera contain antibodies directed at Fab of IgA. J Immunol (1987) 0.88
Value of serologic markers for clinical diagnosis and population studies of coeliac disease. Scand J Gastroenterol (1996) 0.88
Immune complexes, rheumatoid factors, and cellular immunological parameters in patients with giant cell arteritis. Ann Rheum Dis (1981) 0.88
Visceral leishmaniasis in Somalia: prevalence of markers of infection and disease manifestations in a village in an endemic area. Trans R Soc Trop Med Hyg (1995) 0.88
Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells. Scand J Immunol (2007) 0.88
Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate. Eur J Immunol (1998) 0.88
Davos declaration: allergy as a global problem. Allergy (2012) 0.88
Blood supply and vascular pattern of induced primary hepatic carcinoma in rats. A microangiographic and histologic investigation. Acta Pathol Microbiol Scand (1967) 0.87
Contact sensitivity in the murine oral mucosa. I. An experimental model of delayed-type hypersensitivity reactions at mucosal surfaces. Clin Exp Immunol (1991) 0.87
Visceral leishmaniasis in Somalia. Significance of IgG subclasses and of IgE response. Immunol Lett (1996) 0.87
Role of serotonin in the regulation of interferon-gamma production by human natural killer cells. J Interferon Res (1993) 0.87
Dissociation of antibodies bound to surface-immobilized antigen. J Immunol Methods (1985) 0.87
"PERFEXT": a direct method for quantitative assessment of cytokine production in vivo at the local level. Res Immunol (1997) 0.86
Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals. AIDS (1995) 0.86
Linkage analysis of the properdin deficiency gene: suggestion of a locus in the proximal part of the short arm of the X chromosome. Genomics (1988) 0.86